Literature DB >> 26973279

Heart Failure as a Disruption of Dynamic Circulatory Homeostasis Mediated by the Brain.

Takuya Kishi1.   

Abstract

Circulatory homeostasis is associated with interactions between multiple organs, and the disruption of dynamic circulatory homeostasis could be considered as heart failure. The brain is the central unit integrating neural and neurohormonal information from peripheral organs and controlling peripheral organs using the autonomic nervous system. Heart failure is worsened by abnormal sympathoexcitation associated with baroreflex failure and/or chemoreflex activation, and by vagal withdrawal, and autonomic modulation therapies have benefits for heart failure. Recently, we showed that baroreflex failure induces striking volume intolerance independent of left ventricular dysfunction. Many studies have indicated that an overactive renin-angiotensin system, excess oxidative stress and excess inflammation, and/or decreased nitric oxide in the brain cause sympathoexcitation in heart failure. We have demonstrated that angiotensin II type 1 receptor (AT1R)-induced oxidative stress in the rostral ventrolateral medulla (RVLM), which is known as a vasomotor center, causes prominent sympathoexcitation in heart failure model rats. Interestingly, systemic infusion of angiotensin II directly affects brain AT1R with sympathoexcitation and left ventricular diastolic dysfunction. Moreover, we have demonstrated that targeted deletion of AT1R in astrocytes strikingly improved survival with prevention of left ventricular remodeling and sympathoinhibition in myocardial infarction-induced heart failure. From these results, we believe it is possible that AT1R in astrocytes, not in neurons, have a key role in the pathophysiology of heart failure. We would like to propose a novel concept that the brain works as a central processing unit integrating neural and hormonal input, and that the disruption of dynamic circulatory homeostasis mediated by the brain causes heart failure.

Entities:  

Mesh:

Year:  2016        PMID: 26973279     DOI: 10.1536/ihj.15-517

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  6 in total

1.  Augmented fear bradycardia in rats with heart failure.

Authors:  Satoshi Koba; Ichiro Hisatome; Tatsuo Watanabe
Journal:  J Physiol Sci       Date:  2019-07-30       Impact factor: 2.781

2.  Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats.

Authors:  Tomoko Yoshikawa; Takuya Kishi; Keisuke Shinohara; Ko Takesue; Risa Shibata; Noriyuki Sonoda; Toyoshi Inoguchi; Kenji Sunagawa; Hiroyuki Tsutsui; Yoshitaka Hirooka
Journal:  Hypertens Res       Date:  2017-02-16       Impact factor: 3.872

3.  Age-dependent alterations to paraventricular nucleus insulin-like growth factor 1 receptor as a possible link between sympathoexcitation and inflammation.

Authors:  Olalekan M Ogundele; Charles C Lee; Joseph Francis
Journal:  J Neurochem       Date:  2016-10-19       Impact factor: 5.372

Review 4.  Inflammation - Cause or Consequence of Heart Failure or Both?

Authors:  Sophie Van Linthout; Carsten Tschöpe
Journal:  Curr Heart Fail Rep       Date:  2017-08

5.  Disruption of Central Antioxidant Property of Nuclear Factor Erythroid 2-Related Factor 2 Worsens Circulatory Homeostasis with Baroreflex Dysfunction in Heart Failure.

Authors:  Takuya Kishi
Journal:  Int J Mol Sci       Date:  2018-02-25       Impact factor: 5.923

Review 6.  Exercise training to reduce sympathetic nerve activity in heart failure patients. A systematic review and meta-analysis.

Authors:  María Javiera Saavedra; Fernando Romero; Jorge Roa; Iván Rodríguez-Núñez
Journal:  Braz J Phys Ther       Date:  2017-07-07       Impact factor: 3.377

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.